Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium

Clinical Infectious Diseases

Volumn 29, Issue 2, 1999, Pages 361-366

  Weinstein, Mitchell R ^a   Dedier, Helen ^a   Brunton, James ^a   Campbell, Iivi ^a   Conly, John M ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACITRACIN; DOXYCYCLINE; NOVOBIOCIN; RIFAMPICIN; TETRACYCLINE DERIVATIVE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; DRUG EFFICACY; ENTEROCOCCUS FAECIUM; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS;

EID: 0032810102     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520216     Document Type: Article

References (35)

1. 1. LeClercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988;319:157-61.
2. 2. Rubin LG, Tucci V, Cercenado E, Eliopoulos G, Isenberg HD. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol 1992;13:700-5.
3. 3. Courvalin P. Resistance of enterococci to glycopeptides. Antimicrob Agents Chemother 1990;34:2291-6.
4. 4. Conly J, Shafran S. The emerging epidemiology of vancomycin-resistant enterococci in Canada. Can J Infect Dis 1997;8:182-5.
5. 5. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin - United States, 1989-93. MMWR Morb Mortal Wkly Rep 1993;42:597-609.
6. 6. Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Morb Mortal Wkly Rep 1995;44(RR-12):1-13.
7. 7. Boyce JM, Opal SM, Chow JW, et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable van B class vancomycin resistance. J Clin Microbiol 1994;32:1148-53.
8. 8. Boyce JM, Mermel LA, Zervos MJ, et al. Controlling vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 1995;16:634-7.
9. 9. Slaughter S, Hayden MK, Nathan C, et al. A comparison of the effect of universal use of gloves and gowns with that of gloves alone on the acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med 1996;125:448-56.
10. 10. Henning KJ, Delencastre H, Eagan J, et al. Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection. Pediatr Infect Dis J 1996;15:848-54.
11. 11. Montecalvo MA, deLencastre H, Carraher M, et al. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 1995;16:680-5.
12. 12. Livornese LL, Dias S, Samuel C, et al. Hospital acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992;117:112-6.
13. 13. Green M, Barbadora K, Michaels M. Recovery of vancomycin-resistant gram-positive cocci from pediatric liver transplants. J Clin Microbiol 1991;29:2503-6.
14. 14. Noskin GA, Cooper I, Peterson LR. Vancomycin-resistant Enterococcus faecium sepsis following persistent colonization. Arch Intern Med 1995; 1445-7.
15. 15. O'Donovan CA, Fan-Havard P, Tecson-Tumang FT, Smith SM, Eng RH. Enteric eradication of vancomycin-resistant Enterococcus faecium with oral bacitracin. Diagn Microbiol Infect Dis 1994;18:105-9.
16. 16. Montecalvo MA, Horowitz H, Wormser GP, Seiter K, Carbonaro CA. Effect of novobiocin-containing antimicrobial regimens on infection and colonization with vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother 1995;39:794.
17. 17. Dembry LM, Uzokwe K, Zervos MJ. Control of endemic glycopeptide-resistant enterococci. Infect Control Hosp Epidemiol 1996;17:286-92.
18. 18. Chia JKS, Nakata MM, Park S, Lewis RP, Mckee B. Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium. Clin Infect Dis 1995;21:1520.
19. 19. Lior L, Litt M, Hockin J, et al. Vancomycin-resistant enterococci on a renal ward in an Ontario hospital. Can Commun Dis Rep 1996;22: 125-8.
20. 20. Facklam RR, Collins MD. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 1989;27:731-4.
21. 21. Ruoff KL. Streptococcus. In: Murray PR, Baron JE, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. Washington, DC: ASM Press, 1995:299-307.
22. 22. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. 3rd ed. NCCLS document M7-A3. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1993.
23. 23. Dean AG, Dean JA, Coulombier D, et al. Epi Info, version 6.02: a word processing, database and statistics system for public health on IBM-compatible microcomputers. Atlanta: Centers for Disease Control and Prevention, 1994.
24. 24. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Journal of American Statistics Society 1958;53:457-81.
25. 25. Doebbeling BN, Breneman DL, Neu HC, et al. Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. Clin Infect Dis 1993; 17:466-74.
26. 26. Mulligan ME, Murray-Leisure KA, Ribner BS, et al. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993;94:313-8.
27. 27. Eng RHK, Ng K, Smith SM. Susceptibility of resistant Enterococcus faecium to unusual antibiotics. J Antimicrob Chemother 1993;31: 609-10.
28. 28. Jawetz E, Bierman HR. Suppression of the intestinal flora in man by means of mixtures of poorly absorbed antibiotics. Gastroenterology 1952;21: 139-47.
29. 29. Evans PA, Norden CW, Rhoads S, Deobaldia J, Silber JL. In vitro susceptibilities of clinical isolates of vancomycin-resistant enterococci. Antimicrob Agents Chemother 1997;41:1406.
30. 30. Moreno F, Jorgenson JH, Weiner MH. An old antibiotic for a new multiple-resistant Enterococcus faecium. Diagn Microbiol Infect Dis 1994;20:41-3.
31. 31. Nord CE, Heimdahl A. Impact of different antimicrobial agents on the colonization resistance in the intestinal tract with special reference to doxycycline. Scand J Infect Dis Suppl 1988;53:50-8.
32. 32. Mahon WA, Wittenberg JV, Tuffnel PG. Studies on the absorption and distribution of doxycycline in normal patients and in patients with severely impaired renal function. Can Med Assoc J 1970;103:1031-4.
33. 33. Whitman MS, Pitsakis PG, DeJesus E, Osborne AJ, Levison ME, Johnson CC. Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model. Antimicrob Agents Chemother 1996;40:1526-30.
34. 34. Weinstein JW, Tallapragada S, Farrel P, Dembry LM. Comparison of rectal and perirectal swabs for the detection of colonization with vancomycin-resistant enterococci. J Clin Microbiol 1996;34:210-2.
35. 35. Wright J, Dedier H, Zhao J, et al. PCR detection of VanA, VanB, and VanC-1 directly from stool samples/rectal swabs: a rapid and sensitive screening method for detection of VRE [abstract no 017]. Can J Infect Dis 1997;8:362.